Inventor
FERRARA MARCO
IT46 patents
⚠️ This page may combine multiple inventors who share the name “FERRARA MARCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
17 patentsUS10183940B2Jan 22, 2019
Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT2 citations73
US10071974B2Sep 11, 2018
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT2 citations73
US10875867B2Dec 29, 2020
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide
BOEHRINGER INGELHEIM INT3 citations72
US10479794B2Nov 19, 2019
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide
BOEHRINGER INGELHEIM INT3 citations72
US9884854B2Feb 6, 2018
N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT6 citations71
US12351584B2Jul 8, 2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide
BOEHRINGER INGELHEIM INT0 citations62
US11691977B2Jul 4, 2023
Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide
BOEHRINGER INGELHEIM INT0 citations62
US10577336B2Mar 3, 2020
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT1 citations62
US10023575B2Jul 17, 2018
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide
BOEHRINGER INGELHEIM INT1 citations62
US11780827B2Oct 10, 2023
Substituted 3-phenoxyazetidin-1-yl-pyrazines
BOEHRINGER INGELHEIM INT1 citations59
US11236072B2Feb 1, 2022
N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT0 citations59
US10787432B2Sep 29, 2020
N-[(pyridyloxy)propanyl]benzamides
BOEHRINGER INGELHEIM INT0 citations50
US10738031B2Aug 11, 2020
N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity
BOEHRINGER INGELHEIM INT0 citations50
US10710984B2Jul 14, 2020
N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT0 citations50
US10604511B2Mar 31, 2020
N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity
BOEHRINGER INGELHEIM INT0 citations50
US10392369B2Aug 27, 2019
N-[(pyrimidinyloxy)propanyl]benzamides
BOEHRINGER INGELHEIM INT0 citations50
US12115157B2Oct 15, 2024
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament
BOEHRINGER INGELHEIM INT0 citations46
FORM ENERGY INC
9 patentsUS11320796B1May 3, 2022
Renewable energy system controls
FORM ENERGY INC38 citations92
US11416936B1Aug 16, 2022
Systems and methods for managing a renewable power asset
FORM ENERGY INC14 citations83
US11552290B2Jan 10, 2023
Negative electrodes for electrochemical cells
FORM ENERGY INC4 citations70
US12061454B1Aug 13, 2024
Renewable energy system controls
FORM ENERGY INC0 citations60
US11625017B1Apr 11, 2023
Renewable energy system controls
FORM ENERGY INC1 citations60
US11587170B1Feb 21, 2023
Systems and methods for managing a renewable power asset
FORM ENERGY INC0 citations60
US12362352B2Jul 15, 2025
Negative electrodes for electrochemical cells
FORM ENERGY INC0 citations58
US12237548B2Feb 25, 2025
Stack of electric batteries including series of fluidly connected unit cells
FORM ENERGY INC0 citations58
US12261281B2Mar 25, 2025
Metal air electrochemical cell architecture
FORM ENERGY INC0 citations49
IHI INC
5 patentsUS9509176B2Nov 29, 2016
Energy storage modeling and control
IHI INC44 citations95
US10574087B2Feb 25, 2020
Energy storage modeling and control
IHI INC5 citations82
US10170932B2Jan 1, 2019
Energy storage modeling and control
IHI INC6 citations82
US10734811B2Aug 4, 2020
System and method for optimal control of energy storage system
IHI INC8 citations79
US10186902B2Jan 22, 2019
Energy storage modeling and control
IHI INC3 citations71
CENTREXION THERAPEUTICS CORP
3 patentsUS10166214B2Jan 1, 2019
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP4 citations83
US9789082B2Oct 17, 2017
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP5 citations83
US10675268B2Jun 9, 2020
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP2 citations72